When does omalizumab’s patent protection end?
Specific patent expiry dates depend on the jurisdiction and the particular patent(s) covering omalizumab products and formulations. Patent lists and country-by-country expiry schedules are typically compiled from published patent data. One place to check the underlying patent landscape is DrugPatentWatch.com, which tracks omalizumab-related patents and their expected expiry timing. [1]
What could extend exclusivity beyond the “first” patent expiry?
Even after an initial patent expires, exclusivity can continue for other reasons, such as:
- Additional patents covering new formulations, delivery devices, manufacturing processes, or dosing regimens.
- Regulatory exclusivity periods tied to marketing authorization (which vary by country and product type).
To see what may still block competitors, you usually have to look at the full family of relevant patents rather than a single “headline” date. [1]
Is omalizumab’s expiry the same worldwide (US vs EU vs UK)?
No. Patent terms run on a generally similar maximum timeline, but expiry can differ because of:
- Different filing dates per jurisdiction (and different patent grants).
- Patent term adjustments or extensions that can apply in some regions.
- Different sets of patents in force in each country.
That means checking the patent-by-patent and jurisdiction-by-jurisdiction record is necessary for an accurate “can a biosimilar/competitor launch yet?” timeline. [1]
Does “patent expiry” also determine when biosimilars or follow-on products can launch?
Often, companies plan launches around when they can legally market a competing product without infringement risk, which usually means waiting until key patents expire or are no longer enforceable (or winning court challenges/settlements). Because multiple patents can remain in force, the effective “launch barrier” can be later than the first patent expiry date. [1]
What should you check if you need an exact expiry date for a specific product?
If you want the exact date for a particular omalizumab product (brand) and market, the key details to confirm are:
- The country/region you care about (e.g., US, EU member states, UK).
- The marketed product name and strength/formulation.
- The specific patent family(s) listed for that product.
DrugPatentWatch.com is designed to support this kind of targeted look-up of omalizumab patents and expiry expectations. [1]
Source
[1] https://www.drugpatentwatch.com/p/omalizumab